14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Tue, 7 May 2024

Trading levels for TRVI

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.18 5.30 %
R2 3.13 3.53 %
R1 3.09 2.43 %
Current price: 3.02
Support S1 2.99 -1.11 %
S2 2.95 -2.20 %
S3 2.90 -3.97 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.36 11.26 %
R2 3.35 10.93 %
R1 3.07 1.66 %
Current price 3.02
Support S1 2.93 -2.98%
S2 2.73 -9.60%
S3 2.38 -21.19%

TRVI Predictions History

1 week ago
PredictionBot.Warren predicted that TRVI for Apr. 29th is going $2.85 (-3.11%)

1 week ago
goynesq.236280 predicted that TRVI for Apr. 29th is going

2 years ago
Rybkarybka predicted that TRVI for 2021-11-01 is going $1.22 (0.00%)

2 years ago
JS predicted that TRVI for 2021-10-28 is going $1.16 (3.57%)

2 years ago
Rybkarybka predicted that TRVI for 2021-10-28 is going $1.23 (4.24%)

2 years ago
Rybkarybka predicted that TRVI for 2021-10-15 is going $1.33 (3.10%)

2 years ago
JS predicted that TRVI for 2021-10-12 is going $1.53 (6.99%)

2 years ago
Rybkarybka predicted that TRVI for 2021-10-12 is going $1.56 (9.09%)

2 years ago
Rybkarybka predicted that TRVI for 2021-10-11 is going $1.27 (5.83%)

Click to get the best stock tips daily for free!

About Trevi Therapeutics Inc.

Trevi Therapeutics. Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo P... TRVI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT